Fundraising Fox

Lexeotx

New York City, US · Founded 2018 · 101 employees on LinkedIn · 2 known investors

Find your way into Lexeotx

Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.

BiotechDigital HealthHealthtech

Founders & leadership

Lexeotx was founded in 2018 by Ronald Crystal, MD.

RC
Ronald Crystal, MDFounder & Chief Scientific Adviser
RNR. Nolan Townsend
R. Nolan TownsendinChief Executive Officer
NB
Narinder Bhalla, MDChief Medical Officer
JM
José Manuel Otero, PhDChief Operating Officer
LTLouis Tamayo
Louis TamayoinChief Financial Officer

Investors · 2

Longitude CapitalMenlo Park · $10M – $30M
OrbiMedNew York · $1M – $75M

Frequently asked questions

What does Lexeotx do?
Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.
Who founded Lexeotx?
Lexeotx was founded by Ronald Crystal, MD in 2018.
Who are Lexeotx's investors?
Lexeotx's investors include Longitude Capital, OrbiMed.
Where is Lexeotx headquartered?
Lexeotx is headquartered in New York City, US.